glutathione mutations in sclc patients Frontiers Oncology Letters
Oncology Letters The Era of Antibody Drug Conjugates in Lung Cancer: Trick or Threat? JCI Suppression of the SLC7A11 glutathione axis causes synthetic lethality in KRAS mutant lung adenocarcinoma Antibody drug conjugates: A new twist to overcome EGFR TKIs resistance in non small cell lung cancer ScienceDirect Inhibiting the system xC glutathione axis selectively targets cancers with mutant p53 accumulation Nature Communications
Pay in 4 interest-free payments of $6.75 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8



